Pfizer Inc. (Public, NYSE:PFE) got killed this week after they let go of their melanoma drug, Medarax. With shares at just $21 and owning the crown of the world’s largest research-based pharmaceutical company you just have to ask – can’t these guys recover?

Can they recover? More like ‘when they’ recover. But Pfizer has had a run of bad luck, if you can call it that, lately. It started in late 2006 when its hoped-for successor to Lipitor failed. Then, late last year it paid billions of dollars to get out of the new, unsuccessful inhalable diabetic insulin business. Then, early this year safety issues cropped out for its new stop-smoking drug Chantix. The stock is feeling the pain, a slow 1 year decline that is now at $21:

However this is Pfizer we are talking about, they rule the world behind the scenes and will make a comeback. Let the analyst downgrades come in, let us hope the stock continues to fall, then we go in for the kill

This stock is a slow mover and that’s great for this crappy economy and turbulent stock market. Get this stock near the low and just sock it away in your IRA and rest assured a steady 10% return over the next 12 months.

The numbers speak for themselves:

Disclaimer: The Author has no positions in PFE.

Last 5 posts by Ben Stevens

• WaMu (WM) down to $3.60, Kerry you're Fired - September 8th, 2008
• Coal not so cool today: Arch Coal, Peabody fall hard (ACI, BTU) - September 2nd, 2008
• Another blow to the already beat down Whole Foods (WFMI) - August 10th, 2008
• $7 Buys you a pillow but not one share of JetBlue (JBLU) - August 4th, 2008
• AMD: Finally worth a look - July 19th, 2008